Anti-diabetes drug
Drugs used in diabetes to treat diabetes mellitus by altering the glucose level in the blood. With the exceptions of insulin, exenatide, liraglutide and pramlintide, all are administered orally and are thus also known oral hypoglycemia agents or oral anti-hyperglycemia agents. There are different classes of anti-diabetic drugs, and their selection depends upon the nature of the diabetes, age and situation of the person, as well as other factors. Diabetes mellitus type 1 is a disease caused by the shortage of insulin. Insulin must be used in type1, which must be injected. Diabetes mellitus type 2 is a disease of insulin resistance by the cells.
- Types and causes
- Complications
- Diagnosis & Treatment
Related Conference of Anti-diabetes drug
May 05-06, 2025
24th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders
Rome, Italy
May 12-13, 2025
2nd International Congress on Endocrinology and Complications of Diabetes
Rome, Italy
June 24-25, 2025
23rd Global Conference on Diabetes, Endocrinology and Primary Healthcare
Paris, France
November 06-07, 2025
34th International Conference on Clinical Diabetes, Diabetic Medication & Treatment
Berlin, Germany
Anti-diabetes drug Conference Speakers
Recommended Sessions
- Endocrinology
- Anti-diabetes drug
- Diabetes and Cardiovascular diseases
- Diabetes Diagnosis
- Diabetes Nutrition
- Diabetes Treatment
- Diabetic Nephropathy
- Diabetic Neuropathy
- Diabetic retinopathy
- Diabetics complications
- Endocrinology
- Genomic endocrinology
- Gestational Diabetes
- Insulin Therapy
- Metabolism and Differentiation
- Neuroendocrinology
- Pediatric endocrinology
- Prediabetes
- Prevention of Diabetes
- Thyroid disorders and Treatment
- Type 1 diabetes
- Type 2 Diabetes
Related Journals
Are you interested in
- Adrenal and Pituitary Disorders - ENDOCRINOLOGY-2025 (Canada)
- Adrenal Disorders - ENDOCRINOLOGY 2025 (Spain)
- Advances in Diabetes Management - Endocrinology Conference 2025 (France)
- Advances in Endocrinology - ENDOCRINOLOGY-2025 (Canada)
- Advances in Hormone Replacement Therapies - Endocrinology Conference 2025 (France)
- Advances in Insulin and GLP-1 Therapies - Endocrinology Conference 2025 (France)
- AI in Diabetes - DIABETES SUMMIT 2025 (Italy)
- AI in Diabetes Risk Prediction - Diabetes AsiaPacific 2025 (Germany)
- Antidiabetics - DIABETES SUMMIT 2025 (Italy)
- Artificial Intelligence in Diabetes Care - ENDOCRINOLOGY 2025 (Spain)
- Artificial Intelligence in Endocrinology and Diabetes - Endocrinology Conference 2025 (France)
- Artificial Pancreas and Closed-Loop Systems - ENDOCRINOLOGY-2025 (Canada)
- Assessment & Tracking - DIABETES SUMMIT 2025 (Italy)
- Beta Cell Regeneration - Diabetes AsiaPacific 2025 (Germany)
- Biomarker for Diabetes - Global Diabetes 2025 (France)
- Cardiovascular Endocrinology - ENDOCRINOLOGY 2025 (Spain)
- Circadian Rhythms and Insulin Sensitivity - Diabetes AsiaPacific 2025 (Germany)
- Clinical Research and Medical Case Reports - Global Diabetes 2025 (France)
- Clinical Trials and Research for Diabetes - ENDOCRINOLOGY 2025 (Spain)
- Clinical Trials in Endocrinology and Diabetes - Endocrinology Conference 2025 (France)
- Complications of Hormone Replacement Therapy (HRT) - ENDOCRINOLOGY-2025 (Canada)
- Continuous Glucose Monitoring Innovations - Diabetes AsiaPacific 2025 (Germany)
- COVID-19 Impacts in Diabetes - ENDOCRINOLOGY 2025 (Spain)
- CRISPR and Type 1 Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Diabetes and Cancer Connections - Diabetes AsiaPacific 2025 (Germany)
- Diabetes and Cardiovascular Disease: A Dual Epidemic - Endocrinology Conference 2025 (France)
- Diabetes and Cardiovascular Health - ENDOCRINOLOGY-2025 (Canada)
- Diabetes and Cognitive Decline - Diabetes AsiaPacific 2025 (Germany)
- Diabetes and Epigenetics - Diabetes AsiaPacific 2025 (Germany)
- Diabetes and Glucose Metabolism - ENDOCRINOLOGY 2025 (Spain)
- Diabetes and Kidney Disease: From Pathogenesis to Management - Endocrinology Conference 2025 (France)
- Diabetes and Sepsis - ENDOCRINOLOGY 2025 (Spain)
- Diabetes Complications - DIABETES SUMMIT 2025 (Italy)
- Diabetes Complications: Diagnosis and Management - Endocrinology Conference 2025 (France)
- Diabetes Education and Public Health - ENDOCRINOLOGY-2025 (Canada)
- Diabetes in Children and Teens - Global Diabetes 2025 (France)
- Diabetes Research and Therapeutics - ENDOCRINOLOGY-2025 (Canada)
- Diabetes Therapeutics and Diagnostics - ENDOCRINOLOGY 2025 (Spain)
- Diabetes-Related Surgery - DIABETES SUMMIT 2025 (Italy)
- Diabetes: Types and its Complications - Global Diabetes 2025 (France)
- Diabetic Foot and Diabetic Eye Problems - Global Diabetes 2025 (France)
- Diabetic Nephropathy - ENDOCRINOLOGY 2025 (Spain)
- Diabetic Retinopathy - DIABETES SUMMIT 2025 (Italy)
- Diabetic Retinopathy - ENDOCRINOLOGY 2025 (Spain)
- Diabetic Retinopathy and Nephropathy - Global Diabetes 2025 (France)
- Diabetic Retinopathy Detection Advances - Diabetes AsiaPacific 2025 (Germany)
- Digital Therapeutics for Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Emerging Therapies in Thyroid Disorders - Endocrinology Conference 2025 (France)
- Endocrine Complications of Diabetes - ENDOCRINOLOGY-2025 (Canada)
- Endocrine Disease and Cancer - Endocrinology Conference 2025 (France)
- Endocrine Disruptions and Environmental Factors - ENDOCRINOLOGY-2025 (Canada)
- Endocrine Disruptors and Environmental Health - Endocrinology Conference 2025 (France)
- Endocrine Pathophysiology - Endocrinology Conference 2025 (France)
- Endocrine Surgery: Challenges and Innovations - Endocrinology Conference 2025 (France)
- Endocrine Tumors and Neoplasia - ENDOCRINOLOGY 2025 (Spain)
- Endocrinology and Aging - ENDOCRINOLOGY-2025 (Canada)
- Endocrinology and Endocrine Disorders - Global Diabetes 2025 (France)
- Endocrinology and Metabolism - ENDOCRINOLOGY 2025 (Spain)
- Endocrinology in Special Populations - Endocrinology Conference 2025 (France)
- Endoscopic Procedures - DIABETES SUMMIT 2025 (Italy)
- Gender-Specific Approaches in Endocrinology - Endocrinology Conference 2025 (France)
- Genetic Factors - DIABETES SUMMIT 2025 (Italy)
- Genetics and Gene Regulation - ENDOCRINOLOGY 2025 (Spain)
- Genetics and Thyroid Disorders - Global Diabetes 2025 (France)
- Genomics and Molecular Endocrinology - ENDOCRINOLOGY-2025 (Canada)
- Gestational Diabetes (GDM) - Global Diabetes 2025 (France)
- Gestational Diabetes and Reproductive Endocrinology - ENDOCRINOLOGY-2025 (Canada)
- Global Diabetes Awareness and Education - Endocrinology Conference 2025 (France)
- Global Health Strategies for Diabetes and Endocrine Care - Endocrinology Conference 2025 (France)
- Global Trends in Endocrine and Diabetes Care - ENDOCRINOLOGY-2025 (Canada)
- Glycemic Disorder - DIABETES SUMMIT 2025 (Italy)
- Gut Microbiome and Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Herbal and Natural Diabetes Therapies - ENDOCRINOLOGY 2025 (Spain)
- Herbal and Natural therapies in Diabetes - Global Diabetes 2025 (France)
- Hormonal Imbalances and Metabolic Disorders - Endocrinology Conference 2025 (France)
- Hormonal Therapies for Menopause and Aging - Endocrinology Conference 2025 (France)
- Hormone Dependent Cancers - ENDOCRINOLOGY 2025 (Spain)
- Hyperglycemia and Hypoglycemia - Global Diabetes 2025 (France)
- Hyperglycemic Dermatosis - DIABETES SUMMIT 2025 (Italy)
- Immune Therapies for Type 1 Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Inflammation and Insulin Resistance - Diabetes AsiaPacific 2025 (Germany)
- Innovations in Diabetes Prevention - Endocrinology Conference 2025 (France)
- Innovative Technologies in Endocrinology and Diabetes - ENDOCRINOLOGY-2025 (Canada)
- Innovative Therapies and Drug Development - Endocrinology Conference 2025 (France)
- Insulin - DIABETES SUMMIT 2025 (Italy)
- Insulin & Beta-Cells - DIABETES SUMMIT 2025 (Italy)
- Insulin Analogues and Glucose Sensors - Global Diabetes 2025 (France)
- Insulin Devices and Diabetes Medications - Global Diabetes 2025 (France)
- Integrative and Holistic Approaches - ENDOCRINOLOGY-2025 (Canada)
- Ketosis and Diabetic Ketoacidosis - Global Diabetes 2025 (France)
- Lifestyle Influences - DIABETES SUMMIT 2025 (Italy)
- Mental Health in Diabetes Care - Endocrinology Conference 2025 (France)
- Metabolic Kidney Disorder - DIABETES SUMMIT 2025 (Italy)
- Metabolic Reprogramming in Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Metabolic Surgery and Endocrine Outcomes - Endocrinology Conference 2025 (France)
- Metabolic Syndrome and Therapeutics - Global Diabetes 2025 (France)
- Molecular and Cellular endocrinology - Global Diabetes 2025 (France)
- Nanotechnology in Diabetes Treatment - Diabetes AsiaPacific 2025 (Germany)
- Neuroendocrinology and the Brain-Hormone Connection - Endocrinology Conference 2025 (France)
- Nutrition and Healthy diet - Global Diabetes 2025 (France)
- Obesity and Bariatric Surgery - ENDOCRINOLOGY 2025 (Spain)
- Obesity and Insulin Resistance - Endocrinology Conference 2025 (France)
- Obesity and Metabolic Syndrome - ENDOCRINOLOGY-2025 (Canada)
- Obesity and Weight Management - Global Diabetes 2025 (France)
- Obesity and Weight Management - Endocrinology Conference 2025 (France)
- Osteomyelitis and Pathophysiology - Global Diabetes 2025 (France)
- Osteoporosis and Bone Health - ENDOCRINOLOGY 2025 (Spain)
- Pancreas and Diabetes - DIABETES SUMMIT 2025 (Italy)
- Pancreas and Islet Cell Transplantation - Global Diabetes 2025 (France)
- Pancreatic Dysfunction - DIABETES SUMMIT 2025 (Italy)
- Pathophysiology and Causes - DIABETES SUMMIT 2025 (Italy)
- PCOS - DIABETES SUMMIT 2025 (Italy)
- Pediatric Endocrinology - ENDOCRINOLOGY 2025 (Spain)
- Pediatric Endocrinology and Diabetes - ENDOCRINOLOGY-2025 (Canada)
- Pediatric Endocrinology: Advances and Challenges - Endocrinology Conference 2025 (France)
- Personalized and Precision Medicine in Endocrinology - Endocrinology Conference 2025 (France)
- Personalized Diabetes Management - Diabetes AsiaPacific 2025 (Germany)
- Pharmacogenomics in Diabetes - Diabetes AsiaPacific 2025 (Germany)
- Pituitary and Neuroendocrinology - ENDOCRINOLOGY 2025 (Spain)
- Psychosocial Aspects - DIABETES SUMMIT 2025 (Italy)
- Rare Endocrine Disorders - ENDOCRINOLOGY-2025 (Canada)
- Reproductive Endocrinology - ENDOCRINOLOGY 2025 (Spain)
- SGLT2 Inhibitors in Diabetes: - Diabetes AsiaPacific 2025 (Germany)
- Smart Insulin Delivery Systems - Diabetes AsiaPacific 2025 (Germany)
- Stem Cell Therapy for Diabetes: - Diabetes AsiaPacific 2025 (Germany)
- Stem Cell Treatment for Type 2 Diabetes - ENDOCRINOLOGY 2025 (Spain)
- Stroke, Hypertension and Cardiovascular Diseases - Global Diabetes 2025 (France)
- Technological Advances in Diabetes and Endocrinology - Endocrinology Conference 2025 (France)
- The Role of Gut Microbiota in Endocrinology - Endocrinology Conference 2025 (France)
- Thyroid Disorders - ENDOCRINOLOGY 2025 (Spain)
- Thyroid Disorders: Diagnosis and Management - ENDOCRINOLOGY-2025 (Canada)
- Translational Endocrinology and Diabetes Research - ENDOCRINOLOGY-2025 (Canada)
- Type I and Type II Diabetes - Global Diabetes 2025 (France)
- Types of Diabetes - DIABETES SUMMIT 2025 (Italy)